Correlation Between Compal Broadband and SynCore Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Compal Broadband and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compal Broadband and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compal Broadband Networks and SynCore Biotechnology Co, you can compare the effects of market volatilities on Compal Broadband and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compal Broadband with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compal Broadband and SynCore Biotechnology.

Diversification Opportunities for Compal Broadband and SynCore Biotechnology

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Compal and SynCore is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Compal Broadband Networks and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and Compal Broadband is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compal Broadband Networks are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of Compal Broadband i.e., Compal Broadband and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between Compal Broadband and SynCore Biotechnology

Assuming the 90 days trading horizon Compal Broadband Networks is expected to generate 0.87 times more return on investment than SynCore Biotechnology. However, Compal Broadband Networks is 1.15 times less risky than SynCore Biotechnology. It trades about 0.0 of its potential returns per unit of risk. SynCore Biotechnology Co is currently generating about -0.06 per unit of risk. If you would invest  2,885  in Compal Broadband Networks on September 2, 2024 and sell it today you would lose (115.00) from holding Compal Broadband Networks or give up 3.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Compal Broadband Networks  vs.  SynCore Biotechnology Co

 Performance 
       Timeline  
Compal Broadband Networks 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Compal Broadband Networks are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Compal Broadband showed solid returns over the last few months and may actually be approaching a breakup point.
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Compal Broadband and SynCore Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Compal Broadband and SynCore Biotechnology

The main advantage of trading using opposite Compal Broadband and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compal Broadband position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.
The idea behind Compal Broadband Networks and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.